FGFR1 and cancer: To examine whether FGFR inhibitors inhibit the efflux of chemotherapeutic agents from Tx-R cancer cells, we performed FACs analysis of cancer cells treated with PTX or Dox alone and in presence of BGJ 398 (the potent and selective inhibitor of FGFR1-4).